Estuardo Aguilar-Cordova
Founder at CANDEL THERAPEUTICS, INC.
Net worth: 28 M $ as of 2024-05-30
Estuardo Aguilar-Cordova active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CANDEL THERAPEUTICS, INC. | Director/Board Member | 2001-12-31 | - |
| Founder | 2001-12-31 | - | |
| Chief Executive Officer | 2001-12-31 | 2020-08-31 | |
| Chief Tech/Sci/R&D Officer | 2020-08-31 | 2022-02-06 |
Career history of Estuardo Aguilar-Cordova
Former positions of Estuardo Aguilar-Cordova
| Companies | Position | Start | End |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Training of Estuardo Aguilar-Cordova
| California State University-Bakersfield | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
| Universidad Del Valle De Guatemala | Doctorate Degree |
Statistics
International
| United States | 6 |
| Guatemala | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
